We evaluated temporal trends in survival of Swedish acute myeloid leukemia (AML) patients diagnosed between 1973 and 2011 using relative survival ratios (RSRs) and a measure called the loss in expectation of life (LEL). RSRs increased most for patients <60 years at diagnosis during the first calendar periods, but between 1997-2005 and 2006-2011 the most pronounced increase was for those aged 61-70 years at diagnosis; RSR changed from 0.16 (95% confidence interval (CI): 0.13-0.19) to 0.28 (95% CI: 0.23-0.33), respectively. The LEL for males aged 35 years at diagnosis was 41.0 (95% CI: 40.1-41.8) years in 1975 and 19.5 (95% CI: 16.4-22.5) years in 2011. For males aged 65 years, the corresponding figures were 13.8 (95% CI: 13.7-14.0) and 12.0 ...
Variation in survival of pediatric acute myeloid leukemia (pAML) over time and between Western Europ...
Variation in survival of pediatric acute myeloid leukemia (pAML) over time and between Western Europ...
There has been marked improvement in leukemia survival, particularly among children in recent time. ...
We evaluated temporal trends in survival of Swedish acute myeloid leukemia (AML) patients diagnosed ...
The 5-year relative survival of adults diagnosed with acute myeloid leukaemia (AML) was less than 10...
Acute myeloid leukemia (AML) is most common in the elderly, and most elderly are thought to be unfit...
The 5-year relative survival of adults diagnosed with acute myeloid leukaemia (AML) was less than 10...
Purpose: To estimate five-year survival and the proportion of patients ‘cured’ of acute myeloid Leuk...
Acute myeloid leukemia (AML) is most common in the elderly, and most elderly are thought to be unfit...
Treatment of adults with acute myeloblastic leukemia has changed substantially over the past two dec...
Acute Myeloid Leukaemia (AML) is a rare and heterogeneous haematological malignancy with increasing ...
International audienceOBJECTIVE: Little data exist regarding long-term survival in elderly patients ...
Acute Myeloid Leukaemia (AML) is a rare and heterogeneous haematological malignancy with increasing ...
A better understanding of factors associated with early death and survival among children, adolescen...
The outcome of acute myeloid leukemia patients aged 70 years or older is poor. Defining the best tre...
Variation in survival of pediatric acute myeloid leukemia (pAML) over time and between Western Europ...
Variation in survival of pediatric acute myeloid leukemia (pAML) over time and between Western Europ...
There has been marked improvement in leukemia survival, particularly among children in recent time. ...
We evaluated temporal trends in survival of Swedish acute myeloid leukemia (AML) patients diagnosed ...
The 5-year relative survival of adults diagnosed with acute myeloid leukaemia (AML) was less than 10...
Acute myeloid leukemia (AML) is most common in the elderly, and most elderly are thought to be unfit...
The 5-year relative survival of adults diagnosed with acute myeloid leukaemia (AML) was less than 10...
Purpose: To estimate five-year survival and the proportion of patients ‘cured’ of acute myeloid Leuk...
Acute myeloid leukemia (AML) is most common in the elderly, and most elderly are thought to be unfit...
Treatment of adults with acute myeloblastic leukemia has changed substantially over the past two dec...
Acute Myeloid Leukaemia (AML) is a rare and heterogeneous haematological malignancy with increasing ...
International audienceOBJECTIVE: Little data exist regarding long-term survival in elderly patients ...
Acute Myeloid Leukaemia (AML) is a rare and heterogeneous haematological malignancy with increasing ...
A better understanding of factors associated with early death and survival among children, adolescen...
The outcome of acute myeloid leukemia patients aged 70 years or older is poor. Defining the best tre...
Variation in survival of pediatric acute myeloid leukemia (pAML) over time and between Western Europ...
Variation in survival of pediatric acute myeloid leukemia (pAML) over time and between Western Europ...
There has been marked improvement in leukemia survival, particularly among children in recent time. ...